Rheumatoid arthritis

Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive B-cell receptor (BCRs) binding protein modifications

Arthritis Res TherPublished BCR next generation sequencing and re-expression study

Authors' conclusion

The data suggest a possible link between polyreactivity and anti-MDA/MAA autoreactivity in RA-DLBCL lymphomagenesis. We hypothesize that high inflammation burden could increase antigen load which may trigger polyreactive and modified-protein B cell responses and/or maintain lymphoma cell survival.

Study context

Population
Rheumatoid arthritis (RA) patients with concurrent diffuse large B-cell lymphoma (RA-DLBCL) from the Swedish AUTO-LYMPHOMA cohortRA-DLBCL patients included
Participants
22 patients
Outcome
Complete VH/VL lymphoma tissue sequences generated
Methodological detailsSwedish AUTO-LYMPHOMA cohort, multiplex PCR and Illumina sequencing, recombinant monoclonal antibodies, ELISA and solid-phase microarray (> 400 antigens)
  • Swedish AUTO-LYMPHOMA cohort
  • Multiplex PCR and Illumina sequencing
  • Recombinant monoclonal antibodies
  • ELISA and solid-phase microarray (> 400 antigens)

Main finding

As reported in the abstract

RA-DLBCL patients with complete VH/VL sequences
nine
Patients with dominant paired heavy and light chain BCR sequences obtained
six
Clonotype diversity within the tumour
generally low

Observational data: associations, not effects.

Further findings

Intra-clonal evolution

Patients with amino acid variations in the diffuse large B-cell lymphoma (DLBCL) clonotype indicating intra-clonal evolution
three

VH and VL somatic hypermutations

Patients with few mutations (≤ 5 mismatches), of six
Two
Patients with high mutations (> 15 VH or VL mismatches), of six
three
No bias in VH/VL usage

Autoantigen binding of recombinant lymphoma BCRs

Lymphoma BCRs expressed (from five patients)
Six
Bound MDA/MAA-protein
five
Polyreactive binding by in-house assays, of those binding MDA/MAA-protein
Three
Broad polyreactivity on the antigen array, of the three polyreactive
two
All patient-derived lymphoma BCRs CCP2 negative
One patient: lymphoma BCR with high specificity to MDA/MAA-protein; another: binding only to methylated protein

Original publication

Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications. Arthritis Res Ther. Published 27 October 2026. doi:10.1186/s13075-026-03937-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.